Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
Standard
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine. / Odak, Ivan; Riemann, Lennart; Sandrock, Inga; Cossmann, Anne; Ramos, Gema Morillas; Hammerschmidt, Swantje I; Ritter, Christiane; Friedrichsen, Michaela; Hassan, Ahmed; Dopfer-Jablonka, Alexandra; Stankov, Metodi V; Weskamm, Leonie M; Addo, Marylyn M; Ravens, Inga; Willenzon, Stefanie; Schimrock, Anja; Ristenpart, Jasmin; Janssen, Anika; Barros-Martins, Joana; Hansen, Gesine; Falk, Christine; Behrens, Georg M N; Förster, Reinhold.
In: EBIOMEDICINE, Vol. 99, 104947, 01.2024.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
AU - Odak, Ivan
AU - Riemann, Lennart
AU - Sandrock, Inga
AU - Cossmann, Anne
AU - Ramos, Gema Morillas
AU - Hammerschmidt, Swantje I
AU - Ritter, Christiane
AU - Friedrichsen, Michaela
AU - Hassan, Ahmed
AU - Dopfer-Jablonka, Alexandra
AU - Stankov, Metodi V
AU - Weskamm, Leonie M
AU - Addo, Marylyn M
AU - Ravens, Inga
AU - Willenzon, Stefanie
AU - Schimrock, Anja
AU - Ristenpart, Jasmin
AU - Janssen, Anika
AU - Barros-Martins, Joana
AU - Hansen, Gesine
AU - Falk, Christine
AU - Behrens, Georg M N
AU - Förster, Reinhold
N1 - Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2024/1
Y1 - 2024/1
N2 - BACKGROUND: Human immune responses to COVID-19 vaccines display a large heterogeneity of induced immunity and the underlying immune mechanisms for this remain largely unknown.METHODS: Using a systems biology approach, we longitudinally profiled a unique cohort of female high and low responders to the BNT162b vaccine, who were known from previous COVID-19 vaccinations to develop maximum and minimum immune responses to the vaccine. We utilized high dimensional flow cytometry, bulk and single cell mRNA sequencing and 48-plex serum cytokine analyses.FINDINGS: We revealed early, transient immunological and molecular signatures that distinguished high from low responders and correlated with B and T cell responses measured 14 days later. High responders featured a distinct transcriptional activity of interferon-driven genes and genes connected to enhanced antigen presentation. This was accompanied by a robust cytokine response related to Th1 differentiation. Both transcriptome and serum cytokine signatures were confirmed in two independent confirmatory cohorts.INTERPRETATION: Collectively, our data contribute to a better understanding of the immunogenicity of mRNA-based COVID-19 vaccines, which might lead to the optimization of vaccine designs for individuals with poor vaccine responses.FUNDING: German Center for Infection Research, German Center for Lung Research, German Research Foundation, Excellence Strategy EXC 2155 "RESIST" and European Regional Development Fund.
AB - BACKGROUND: Human immune responses to COVID-19 vaccines display a large heterogeneity of induced immunity and the underlying immune mechanisms for this remain largely unknown.METHODS: Using a systems biology approach, we longitudinally profiled a unique cohort of female high and low responders to the BNT162b vaccine, who were known from previous COVID-19 vaccinations to develop maximum and minimum immune responses to the vaccine. We utilized high dimensional flow cytometry, bulk and single cell mRNA sequencing and 48-plex serum cytokine analyses.FINDINGS: We revealed early, transient immunological and molecular signatures that distinguished high from low responders and correlated with B and T cell responses measured 14 days later. High responders featured a distinct transcriptional activity of interferon-driven genes and genes connected to enhanced antigen presentation. This was accompanied by a robust cytokine response related to Th1 differentiation. Both transcriptome and serum cytokine signatures were confirmed in two independent confirmatory cohorts.INTERPRETATION: Collectively, our data contribute to a better understanding of the immunogenicity of mRNA-based COVID-19 vaccines, which might lead to the optimization of vaccine designs for individuals with poor vaccine responses.FUNDING: German Center for Infection Research, German Center for Lung Research, German Research Foundation, Excellence Strategy EXC 2155 "RESIST" and European Regional Development Fund.
U2 - 10.1016/j.ebiom.2023.104947
DO - 10.1016/j.ebiom.2023.104947
M3 - SCORING: Journal article
C2 - 38160529
VL - 99
JO - EBIOMEDICINE
JF - EBIOMEDICINE
SN - 2352-3964
M1 - 104947
ER -